Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chutkow, W. A.
Right arrow Articles by Burant, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chutkow, W. A.
Right arrow Articles by Burant, C. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 10 1439-1445, Copyright © 1996 by American Diabetes Association


ARTICLES

Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels

WA Chutkow, MC Simon, MM Le Beau and CF Burant
Department of Medicine, Howard Hughes Medical Institute, Chicago, Illinois, USA.

ATP-sensitive inwardly rectifying potassium channels are expressed in a variety of tissues, including heart, skeletal, and smooth muscle, and pancreatic beta-cells. Physiological and pharmacological studies suggest the presence of distinct KATP channels in these tissues. Recently, the KATP channel of beta-cells has been reconstituted in functional form by coexpression of SUR, the sulfonylurea-binding protein, and the inwardly rectifying K+ channel subunit, KIR6.2. In this article, we describe the isolation of cDNAs encoding SUR-like proteins from mouse, SUR2A and SUR2B. Northern blotting showed that the highest expression of the SUR2 isoforms is in the heart and skeletal muscle, with lower levels in all other tissues. By reverse transcription-polymerase chain reaction, SUR2B is ubiquitously expressed, while the apparently alternatively spliced variant, SUR2A, is expressed exclusively in heart. In situ hybridization shows that the SUR2 isoforms are expressed in the parenchyma of the heart and skeletal muscle and in the vascular structures of other tissues. Human SUR2 was localized to chromosome 12, p12.1 by fluorescent in situ hybridization. The structure of the predicted protein and expression pattern of SUR2 suggests that it is the drug-binding channel-modulating subunit of the extrapancreatic KATP channel. Differences in sequence between SUR and between SUR2 isoforms may underlie the tissue-specific pharmacology of the KATP channel.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
M. Zhou, H.-J. He, R. Suzuki, K.-X. Liu, O. Tanaka, M. Sekiguchi, H. Itoh, K. Kawahara, and H. Abe
Localization of Sulfonylurea Receptor Subunits, SUR2A and SUR2B, in Rat Heart
J. Histochem. Cytochem., August 1, 2007; 55(8): 795 - 804.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Misaki, X. Mao, Y.-F. Lin, S. Suga, G.-H. Li, Q. Liu, Y. Chang, H. Wang, M. Wakui, and J. Wu
Iptakalim, a Vascular ATP-Sensitive Potassium (KATP) Channel Opener, Closes Rat Pancreatic beta-Cell KATP Channels and Increases Insulin Release
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Giannico, P. Cortes, M. H. Baccora, C. Hassett, D. W. Taube, and J. Yee
Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F57 - F65.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Kakkar, B. Ye, D. A. Stoller, M. Smelley, N.-Q. Shi, K. Galles, M. Hadhazy, J. C. Makielski, and E. M. McNally
Spontaneous Coronary Vasospasm in KATP Mutant Mice Arises From a Smooth Muscle-Extrinsic Process
Circ. Res., March 17, 2006; 98(5): 682 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Shimomura, H. Shimizu, M. Ikeda, S. Okada, M. Kakei, S. Matsumoto, and M. Mori
Fenofibrate, Troglitazone, and 15-Deoxy-{Delta}12,14-prostaglandin J2 Close KATP Channels and Induce Insulin Secretion
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1273 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Seino and T. Miki
Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice
J. Physiol., January 15, 2004; 554(2): 295 - 300.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J J Meier, B Gallwitz, W E Schmidt, A Mugge, and M A Nauck
Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?
Heart, January 1, 2004; 90(1): 9 - 12.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Cartier, S. Shen, and S.-L. Shyng
Modulation of the Trafficking Efficiency and Functional Properties of ATP-sensitive Potassium Channels through a Single Amino Acid in the Sulfonylurea Receptor
J. Biol. Chem., February 21, 2003; 278(9): 7081 - 7090.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. J. Grover, A. J. D'Alonzo, R. B. Darbenzio, C. S. Parham, T. A. Hess, and M. S. Bathala
In Vivo Characterization of the Mitochondrial Selective KATP Opener (3R)-trans-4-((4-Chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril Monohydrochloride (BMS-191095): Cardioprotective, Hemodynamic, and Electrophysiological Effects
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 132 - 140.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Hambrock, R. Preisig-Muller, U. Russ, A. Piehl, P. J. Hanley, J. Ray, J. Daut, U. Quast, and C. Derst
Four novel splice variants of sulfonylurea receptor 1
Am J Physiol Cell Physiol, August 1, 2002; 283(2): C587 - C598.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Hasko, E. A. Deitch, Z. H. Nemeth, D. G. Kuhel, and C. Szabo
Inhibitors of ATP-Binding Cassette Transporters Suppress Interleukin-12 p40 Production and Major Histocompatibility Complex II Up-Regulation in Macrophages
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. R. Pelletier, P. A. Pahapill, P. S. Pennefather, and P. L. Carlen
Analysis of Single KATP Channels in Mammalian Dentate Gyrus Granule Cells
J Neurophysiol, November 1, 2000; 84(5): 2291 - 2301.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Morishita, Y. Iwasaki, E. Yamamori, A. Nomura, N. Mutsuga, M. Yoshida, M. Asai, Y. Oiso, and H. Saito
Antidiabetic Sulfonylurea Enhances Secretagogue-Induced Adrenocorticotropin Secretion and Proopiomelanocortin Gene Expression in Vitro
Endocrinology, September 1, 2000; 141(9): 3313 - 3318.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. IKENAGA, J. P. BAST, R. W. FALLET, and P. K. CARMINES
Exaggerated Impact of ATP-Sensitive K+ Channels on Afferent Arteriolar Diameter in Diabetes Mellitus
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1199 - 1207.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne
Hyperinsulinism of infancy: towards an understanding of unregulated insulin release
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 87F - 97.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Hu, S. Wang, and B. E. Dunning
Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and beta -Cell KATP Channels
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1372 - 1379.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
I. Gross, A. Toman, I. Uhde, C. Schwanstecher, and M. Schwanstecher
ACCELERATED COMMUNICATION: Stoichiometry of Potassium Channel Opener Action
Mol. Pharmacol., December 1, 1999; 56(6): 1370 - 1373.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. Baron, L. van Bever, D. Monnier, A. Roatti, and A. J. Baertschi
A Novel KATP Current in Cultured Neonatal Rat Atrial Appendage Cardiomyocytes
Circ. Res., October 15, 1999; 85(8): 707 - 715.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Uhde, A. Toman, I. Gross, C. Schwanstecher, and M. Schwanstecher
Identification of the Potassium Channel Opener Site on Sulfonylurea Receptors
J. Biol. Chem., October 1, 1999; 274(40): 28079 - 28082.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Proks, R. Ashfield, and F. M. Ashcroft
Interaction of Vanadate with the Cloned Beta Cell KATP Channel
J. Biol. Chem., September 3, 1999; 274(36): 25393 - 25397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Dörschner, I. Uhde, C. Schwanstecher, and M. Schwanstecher
Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure
Mol. Pharmacol., June 1, 1999; 55(6): 1060 - 1066.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. A. Chutkow, J. C. Makielski, D. J. Nelson, C. F. Burant, and Z. Fan
Alternative Splicing of sur2 Exon 17 Regulates Nucleotide Sensitivity of the ATP-sensitive Potassium Channel
J. Biol. Chem., May 7, 1999; 274(19): 13656 - 13665.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev., April 1, 1999; 20(2): 101 - 135.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. M. Gribble, P. Proks, B. E. Corkey, and F. M. Ashcroft
Mechanism of Cloned ATP-sensitive Potassium Channel Activation by Oleoyl-CoA
J. Biol. Chem., October 9, 1998; 273(41): 26383 - 26387.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Kersten, T. J. Schmeling, K. G. Orth, P. S. Pagel, and D. C. Warltier
Acute hyperglycemia abolishes ischemic preconditioning in vivo
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H721 - H725.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. M. Gribble, S. J. Tucker, T. Haug, and F. M. Ashcroft
MgATP activates the beta  cell KATP channel by interaction with its SUR1 subunit
PNAS, June 9, 1998; 95(12): 7185 - 7190.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. P. Wei, H. A. Kontos, J. S. Beckman, and F. M. Faraci
Antioxidants Inhibit ATP-Sensitive Potassium Channels in Cerebral Arterioles • Editorial Comment
Stroke, April 1, 1998; 29(4): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. A. Kontos and E. P. Wei
Cerebral arteriolar dilations by KATP channel activators need L-lysine or L-arginine
Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H974 - H981.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. AGUILAR-BRYAN, J. P. CLEMENT IV, G. GONZALEZ, K. KUNJILWAR, A. BABENKO, and J. BRYAN
Toward Understanding the Assembly and Structure of KATP Channels
Physiol Rev, January 1, 1998; 78(1): 227 - 245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Yokoshiki, M. Sunagawa, T. Seki, and N. Sperelakis
ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 1998; 274(1): C25 - C37.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. McNicholas, M. W. Nason Jr., W. B. Guggino, E. M. Schwiebert, S. C. Hebert, G. Giebisch, and M. E. Egan
A functional CFTR-NBF1 is required for ROMK2-CFTR interaction
Am J Physiol Renal Physiol, November 1, 1997; 273(5): F843 - F848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Fan and J. C. Makielski
Anionic Phospholipids Activate ATP-sensitive Potassium Channels
J. Biol. Chem., February 28, 1997; 272(9): 5388 - 5395.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Hernandez-Sanchez, T. L. Wood, and D. LeRoith
Developmental and Tissue-Specific Sulfonylurea Receptor Gene Expression
Endocrinology, February 1, 1997; 138(2): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-K. Song and F. M. Ashcroft
ATP Modulation of ATP-sensitive Potassium Channel ATP Sensitivity Varies with the Type of SUR Subunit
J. Biol. Chem., March 2, 2001; 276(10): 7143 - 7149.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Hernandez-Sanchez, A. S. Basile, I. Fedorova, H. Arima, B. Stannard, A. M. Fernandez, Y. Ito, and D. LeRoith
Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death
PNAS, March 13, 2001; 98(6): 3549 - 3554.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. A. Chutkow, V. Samuel, P. A. Hansen, J. Pu, C. R. Valdivia, J. C. Makielski, and C. F. Burant
Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle
PNAS, September 25, 2001; 98(20): 11760 - 11764.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.